Avalo Therapeutics Inc (AVTX): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 44,083 US Dollar | 12 | 2 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 53.629.989 | 21,3 | 9,77 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Avalo Therapeutics Inc
Mitarbeiter 33
Handelsplatz NASDAQ
Ticker Symbol AVTX
IPO Datum 2015-11-13
Adresse 1500 Liberty Ridge Drive, Wayne, PA, United States, 19087
Webseite https://www.avalotx.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Garry A. Neil M.D. | President, CEO & Director |
| 2 | Dr. Mittie Doyle FACR, M.D. | Chief Medical Officer |
| 3 | Mr. Taylor Boyd | Chief Business Officer |
| 4 | Dr. Solomon H. Snyder M.D. | Founder and Chairman of Scientific Advisory Board |
| 5 | Dr. Barbara S. Slusher Ph.D. | Founder and Member of Scientific Advisory Board |
| 6 | Mr. Christopher Ryan Sullivan CPA | CFO & Head of Investor relations |
| 7 | Mr. Paul C. Varki J.D., M.P.H | Chief Legal Officer |
| 8 | Ms. Ashley Ivanowicz | Senior Vice President of Human Resources |
| 9 | Dr. Dino C. Miano Ph.D. | Senior Vice President of CMC & Technical Operations |
| 10 | Ms. Jennifer Riley | Chief Strategy Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | FMR Inc | 9,51% | 69,62 Mio. USD |
| 2 | BlackRock Inc | 8,14% | 59,59 Mio. USD |
| 3 | Nantahala Capital Management, LLC | 6,94% | 50,84 Mio. USD |
| 4 | Deep Track Capital, LP | 6,73% | 49,28 Mio. USD |
| 5 | Caligan Partners LP | 5,90% | 43,19 Mio. USD |
| 6 | TCG Crossover Management, LLC | 5,63% | 41,18 Mio. USD |
| 7 | Affinity Asset Advisors, LLC | 5,41% | 39,59 Mio. USD |
| 8 | State Street Corp | 5,39% | 39,44 Mio. USD |
| 9 | Farallon Capital Management, L.L.C. | 4,66% | 34,10 Mio. USD |
| 10 | Point72 Asset Management, L.P. | 4,45% | 32,58 Mio. USD |
| 11 | venBio Select Advisor LLC | 4,35% | 31,85 Mio. USD |
| 12 | Vanguard Capital Management, LLC | 4,22% | 30,91 Mio. USD |
| 13 | Bvf Inc | 3,87% | 28,33 Mio. USD |
| 14 | Bank of America Corp | 3,57% | 26,12 Mio. USD |
| 15 | Adage Capital Partners Gp LLC | 3,22% | 23,60 Mio. USD |
| 16 | Soleus Capital Management, L.P. | 3,09% | 22,59 Mio. USD |
| 17 | BRAIDWELL LP | 3,04% | 22,24 Mio. USD |
| 18 | T. Rowe Price Associates, Inc. | 2,45% | 17,91 Mio. USD |
| 19 | AllianceBernstein L.P. | 2,35% | 17,21 Mio. USD |
| 20 | UBS Group AG | 2,25% | 16,50 Mio. USD |